2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO18] Mini-Oral Session 18　Breast Cancer 1（Systemic treatment, Survivership）
【E】

Thu. Feb 17, 2022 1:10 PM - 2:00 PM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Kazuhiro Araki（Department of Medical Oncology, Gunma Prefctral Cancer Center），Yasuhiro Yanagita（Department of Breast Oncology, Gunma Prefectural Cancer Center）

[MO18-2] A phase II trial of neoadjuvant apatinib combined with nab-paclitaxel and carboplatin in triple-negative breast cancer

○Tianyu Zeng1, Jue Wang2, Wei Li1, Chunxiao Sun1, Fan Yang1, Yan Liang1, Ziyi Fu1, Xiaoming Zha2, Yongmei Yin1 (1.Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, 2.Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password